Hansson, L; Zanchetti, A; Carruthers, S G; Dahlöf, B; Elmfeldt, D; Julius, S; Ménard, J; Rahn, K H; Wedel, H; Westerling, S
Lancet; 1998 Jun 13;351(9118):1755-62. PMID: 9635947
Abstract
Despite treatment, there is often a higher incidence of cardiovascular complications in patients with hypertension than in normotensive individuals. Inadequate reduction of their blood pressure is a likely cause, but the optimum target blood pressure is not known. The impact of acetylsalicylic acid (aspirin) has never been investigated in patients with hypertension. We aimed to assess the optimum target diastolic blood pressure and the potential benefit of a low dose of acetylsalicylic acid in the treatment of hypertension.